NCT00543920View on ClinicalTrials.gov

A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions
Anxiety Disorders
Interventions
DRUG

MK0777

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00543920 - A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020) | Biotech Hunter | Biotech Hunter